Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Opus Genetics Inc banner

Opus Genetics Inc
NASDAQ:IRD

Watchlist Manager
Opus Genetics Inc Logo
Opus Genetics Inc
NASDAQ:IRD
Watchlist
Price: 2.931 USD 13.6% Market Closed
Market Cap: $202.1m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+148%
5Y
+309%
10Y
+57%
Liabilities
+
3Y
+1 021%
5Y
+867%
10Y
+462%
Equity
+
3Y
-50%
5Y
+5%
10Y
-66%

Balance Sheet Decomposition
Opus Genetics Inc

Balance Sheet
Opus Genetics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
0
0
2
4
4
0
7
12
10
13
19
10
10
12
9
9
9
16
25
43
51
30
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
0
0
2
4
4
0
7
12
10
13
19
10
10
12
9
9
9
16
25
43
51
30
Short-Term Investments
0
1
8
0
4
3
0
2
2
0
0
23
13
9
18
6
3
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
2
6
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
2
6
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
1
0
0
1
0
0
1
1
1
1
1
1
0
1
1
1
1
1
Total Current Assets
0
1
10
5
8
4
8
16
12
14
19
33
25
21
28
16
13
18
26
49
54
37
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
2
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
0
N/A
1
+917%
11
+779%
5
-53%
8
+70%
4
-52%
10
+143%
16
+62%
14
-16%
15
+9%
20
+31%
34
+71%
25
-26%
21
-15%
28
+34%
16
-43%
13
-19%
18
+36%
26
+48%
49
+88%
54
+10%
37
-32%
Liabilities
Accounts Payable
0
0
1
1
0
0
0
0
1
0
0
1
1
0
1
1
0
1
2
1
2
3
Accrued Liabilities
0
0
0
0
0
0
1
1
1
1
1
2
2
1
2
3
1
2
2
1
2
8
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
Total Current Liabilities
0
0
1
1
1
0
1
2
1
1
1
2
3
2
3
3
3
3
4
3
4
11
Long-Term Debt
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
1
1
1
1
1
4
4
2
5
6
4
3
2
8
2
0
28
0
0
0
0
Total Liabilities
0
N/A
2
+3 480%
6
+229%
2
-70%
2
-3%
1
-18%
5
+261%
6
+14%
3
-49%
5
+81%
7
+29%
7
+0%
6
-13%
4
-34%
12
+189%
5
-52%
3
-45%
31
+935%
4
-88%
3
-29%
4
+47%
11
+179%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19
Retained Earnings
0
8
14
21
25
30
32
46
57
63
73
91
106
115
140
155
163
33
89
71
81
139
Additional Paid In Capital
0
7
19
24
32
33
37
56
68
73
85
118
124
132
157
165
173
19
112
118
131
146
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
0
N/A
1
N/A
5
N/A
3
-33%
7
+110%
3
-60%
5
+81%
10
+112%
11
+3%
10
-11%
13
+33%
27
+110%
19
-29%
17
-9%
17
-2%
11
-37%
10
-6%
13
N/A
22
N/A
46
+108%
50
+8%
26
-49%
Total Liabilities & Equity
0
N/A
1
+917%
11
+779%
5
-53%
8
+70%
4
-51%
10
+142%
16
+62%
14
-16%
15
+9%
20
+31%
34
+71%
25
-26%
21
-15%
28
+34%
16
-43%
13
-19%
18
+36%
26
+48%
49
+88%
54
+10%
37
-32%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
11
19
21
24
32

See Also

Summary
IRD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IRD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IRD stock valuation using valuation multiples.
Wall Street Estimates
IRD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IRD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.